Cancer Drug Development: New Directions and Challenges--SMi Conference.  10-11 March 2003, London, UK.
Erlich
Rebecca
R
Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK. rebecca.erlich@current-drugs.com
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D014780:Viruses / Q000187:drug effects
D000276:Adjuvants, Immunologic; D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents